evenfolioETF Details
Virtus·Health·BBC · NYSE Arca
Virtus Biotech Clinical Trials ETF (BBC)
- Price
- $43.05
- —30 Oct 2026
- Assets
- $43.8M
- Total net assets
- Expense ratio
- 0.65%
- Category 1.00%
- Yield
- 1.42%
- Trailing distributions
- 1Y return
- 36.6%+7.8%
- Category 28.8%
- 3Y CAGR
- 36.8%+15.2%
- Category 21.5%
- 5Y CAGR
- 0.0%-4.1%
- Category 4.1%
Loading NAV history…
Virtus Biotech Clinical Trials ETF
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily closes. Risk-free rate 4% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
| Period | 1M | 3M | 6M | YTD | 1Y | 3YCAGR | 5YCAGR | 10YCAGR | LaunchCAGR |
|---|---|---|---|---|---|---|---|---|---|
| ETF | -7.0% | -11.7% | -1.8% | +11.6% | +36.6% | +36.8% | 0.0% | +9.4% | +4.5% |
| Health average | 3.6% | 9.9% | 23.0% | 20.4% | 28.8% | 21.5% | 4.1% | 10.8% | 11.6% |
| Difference | -10.6% | -21.6% | -24.8% | -8.8% | +7.8% | +15.2% | -4.1% | -1.5% | -7.1% |
Holdings
The 10 largest positions make up 14.2% of the fund.
Top holdings
| Ticker | Holding | Weight |
|---|---|---|
| ABCL | AbCellera Biologics Inc Ordinary Shares | 2.02% |
| KOD | Kodiak Sciences Inc | 2.01% |
| XNCR | Xencor Inc | 1.46% |
| TRAX | First Tracks Biotherapeutics Inc | 1.45% |
| AMLX | Amylyx Pharmaceuticals Inc | 1.44% |
| MBX | MBX Biosciences Inc | 1.20% |
| ORIC | ORIC Pharmaceuticals Inc | 1.18% |
| FDMT | 4D Molecular Therapeutics Inc Ordinary Shares | 1.17% |
| SLS | SELLAS Life Sciences Group Inc | 1.14% |
| ANL | Adlai Nortye Ltd ADR | 1.12% |
Portfolio valuation
Weighted averages of what the fund holds.
- P/E
- —
- P/B
- 2.9
- P/S
- —
- P/CF
- —
Sector allocation
Share of the equity the fund holds.
- Health care100.0%
Asset mix
- Stocks99.9%
- Cash0.1%
ETF details
- Issuer
- Virtus
- Category
- Equity · Health
- Ticker
- BBC
- Exchange
- NYSE Arca
- Inception
- 16 Dec 2014 (11.9 years)
- Structure
- Exchange Traded Fund
- Expense ratio
- 0.65% (category 1.00%)
- Holdings turnover
- 77% (category 51%)
- Distribution yield
- 1.42%
- Beta, 3 years
- 1.20
- Total net assets
- $43.8M
Prices and returns as of 30 Oct 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.
Other health ETFs
Other ETFs in the Health category.
- MEDI · Harbor Health Care ETFHarbor Capital Advisors Inc · $41.7M · ER 0.80%
- HELX · Franklin Genomic Advancements ETFFranklin Templeton, Inc · $33.4M · ER 0.50%5Y -3.1%
- TMED · T. Rowe Price Health Care ETFT. Rowe Price · $33M · ER 0.44%
- HEAL · Global X HealthTech ETFGlobal X Funds · $31M · ER 0.50%5Y -10.9%
- GDOC · Future Health Care Equity ETFGoldman Sachs · $19.5M · ER 0.75%
- MEDX · Horizon Kinetics Medical ETFHorizon Kinetics · $16.5M · ER 0.85%